Tryp Therapeutics Inc (TRYPF) Corporate Presentation

Corporate Presentation Fall 2021 UNLEASHING THE FULL POTENTIAL OF PSILOCYBIN Tryp differs from other psychedelic drug development companies in four important ways: 6 A proprietary formulation and delivery method Our psilocybin-based drug product, TRPՓ8803, features a proprietary formulation and novel method of administration to improve the patient experience. We have filed a provisional patent to protect the unique features of TRPՓ8803—a foundational piece of intellectual property for Tryp. 02